Trending
World Cup 2026ExplainerEvidence packHistoryMyanmar conflictLooking backClimate policyClimate metricsImmigration lawClimate modelsEducation policyHigher ed policyMedia regulationTipping pointsIndustrial policyTactical evolutionIndustry shiftPolicy explainerMilestone reportRegulatory rollbackPolicy decisionLegislative moveExecutive actionConstitutional clashDiplomatic crisisMatch recapDemographic shiftAi workforceFood deliveryF1 driver marketRiver cruising

Mental Health

All HealthNutrition & DietSupplementsMental HealthSleepLongevityMedicineMedications & TreatmentsConditions & DiseasesHormones & EndocrinologySkincareDental HealthFamily HealthChildren's HealthMen's HealthWomen's HealthAging & GeroscienceBiohackingAlternative MedicinePublic HealthMedical ResearchPreventive WellnessHealthy Habits
Psychiatric Genetics

Landmark Genetic Study Finds Schizophrenia and Bipolar Disorder Share 70% of Underlying Risk

4 sources · 8d ago

Factlen Explainer

FDA Approves First Non-Antipsychotic Drug to Treat Agitation in Alzheimer's Disease

3 sources · 10d ago

Factlen Research

Psilocybin Completes Second Pivotal Phase 3 Trial, Paving Way for FDA Review in Depression

5 sources · 11d ago

More in Mental Health

Factlen ResearchCare Integration

Landmark Study: Integrating Suicide Care Into Routine Primary Care Slashes Attempt Rates by 25%

Clinical Researchers 40%Primary Care Providers 35%Patient Advocacy Groups 25%

5 sources · 12d ago

Factlen ExplainerNeurotherapeutics

Landmark Research: Non-Hallucinogenic 'Psychoplastogen' Molecules Retain Therapeutic Effect for Depression and Anxiety

Neuroplasticity Researchers 40%Clinical Development & Industry 40%Independent Clinical Analysts 20%

4 sources · 13d ago

Factlen ExplainerPsychedelic Medicine

The Evidence Pack: Why the FDA Declined MDMA-Assisted Therapy for PTSD

Regulatory & Methodological Skeptics 40%Psychedelic Researchers & Advocates 30%Patient Advocates & Veterans 30%

5 sources · 14d ago

Addiction MedicineEvidence Pack

FDA Fast-Tracks First Ibogaine Derivative Trial for Alcohol Use Disorder

Psychedelic Medicine Advocates 40%Public Health & Policy Officials 35%Clinical Safety Skeptics 25%

3 sources · 15d ago

Factlen ExplainerPsychedelic Medicine

Landmark Phase 3 Trial Finds Single-Dose Psilocybin Provides Six-Month Relief for Severe Depression

Clinical Researchers 44%Healthcare Administrators 33%Patient Advocates 22%

6 sources · 15d ago

Factlen ExplainerMetabolic Psychiatry

Landmark Research Suggests Mental Illness Starts in Brain Cells, Shifting Focus From Neurotransmitters to Cellular Metabolism

Metabolic Psychiatry Pioneers 45%Traditional Neurobiologists 35%Clinical Innovators 20%

4 sources · 17d ago

Factlen ExplainerPsychedelic Therapy

The Evidence Pack: How the White House Mandate is Accelerating Psychedelic Medicine

Clinical Researchers & Drug Sponsors 40%Veteran & Patient Advocates 35%Regulatory Skeptics 25%

6 sources · 17d ago

Factlen ResearchPsychiatric Care

The Evidence Pack: How the WHO's New Initiative Aims to Close the Schizophrenia Mortality Gap

Public Health Officials 40%Psychiatric Clinicians 35%Patient Advocacy Groups 25%

5 sources · 18d ago

Factlen ExplainerPsychiatric Care

HHS Launches Landmark Action Plan to Curb Psychiatric Overprescribing and Promote Safe Deprescribing

Public Health Officials 35%Clinical Psychiatrists 35%Patient Advocacy Groups 30%

6 sources · 19d ago

Explore more topics

News & PoliticsWorldBusinessFinanceTechnologyArtificial IntelligenceScienceEnergy